Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

75.56
Delayed Data
As of 4:00pm ET
 -0.12 / -0.16%
Today’s Change
51.82
Today|||52-Week Range
77.12
+9.84%
Year-to-Date
Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2
12:21pm / Zacks.com - Paid Partner Content
Barron's Picks And Pans: Pharmacy-Benefit Managers, Mortgage Insurers And More
Jul 24 / Benzinga - Paid Partner Content
Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen
10:02am / Zacks.com - Paid Partner Content
In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October
Jul 23 / MotleyFool.com - Paid Partner Content
Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?
9:29am / Zacks.com - Paid Partner Content
Pharma Industry Outlook: Fundamentals Remain Strong
Jul 22 / Zacks.com - Paid Partner Content
Agenus (AGEN): What's Ahead for the Stock in Q2 Earnings?
9:29am / Zacks.com - Paid Partner Content
Synta (SNTA) Cuts Q2 Loss Y/Y, Madrigal Merger in Focus
Jul 22 / Zacks.com - Paid Partner Content
Bristol-Myers a Strong Biopharma Pick
3:02am / GuruFocus News - Paid Partner Content
Will Q2 Earnings Hold a Surprise for Nielsen (NLSN) Stock?
Jul 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close75.68
Today’s open75.73
Day’s range75.07 - 75.75
Volume3,983,000
Average volume (3 months)5,864,243
Market cap$126.3B
Dividend yield2.01%
Data as of 4:00pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)-22.50%
Earnings growth (this year)+28.66%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)+4.29%
P/E ratio81.2
Price/Sales6.97
Price/Book8.81

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.17-0.40%
NVONovo Nordisk-0.33-0.59%
GSKGlaxoSmithKline+0.16+0.36%
ABBVAbbVie+0.51+0.80%
Data as of 4:03pm ET, 07/25/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.66
Annual revenue (last year)$16.6B
Annual profit (last year)$1.6B
Net profit margin9.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Giovanni Caforio
Chief Financial Officer &
Executive Vice President
Charles A. Bancroft
Corporate headquarters
New York, New York

Forecasts

Partner Offers

Search for Jobs